Please login to the form below

Not currently logged in
Email:
Password:

deutetrabenazine

This page shows the latest deutetrabenazine news and features for those working in and with pharma, biotech and healthcare.

Teva will have to endure revenue 'trough' in 2019

Teva will have to endure revenue 'trough' in 2019

To reverse the trend, Teva needs new products such as migraine prevention therapy Ajovy (fremanezumab) and Austedo (deutetrabenazine) for tardive dyskinesia and chorea associated with Huntington’s disease to ramp up

Latest news

More from news
Approximately 2 fully matching, plus 9 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...

Infographics